K042644 is an FDA 510(k) clearance for the AESKULISA TTG A AND AESKULISA TTG G. This device is classified as a Autoantibodies, Endomysial(tissue Transglutaminase) (Class II - Special Controls, product code MVM).
Submitted by Aesku, Inc. (Miami, US). The FDA issued a Cleared decision on June 1, 2005, 247 days after receiving the submission on September 27, 2004.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.
| 510(k) Number | K042644 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 27, 2004 |
| Decision Date | June 01, 2005 |
| Days to Decision | 247 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | MVM — Autoantibodies, Endomysial(tissue Transglutaminase) |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5660 |